Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
36.35
+0.07 (0.19%)
At close: Aug 15, 2025, 4:00 PM
36.11
-0.24 (-0.66%)
After-hours: Aug 15, 2025, 7:54 PM EDT
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $21.20 billion as of August 15, 2025. Its market cap has increased by 66.45% in one year.
Market Cap
21.20B
Enterprise Value
28.57B
1-Year Change
66.45%
Ranking
Category
Stock Price
$36.35
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $15.76B to $21.20B, an increase of 34.50%. That is a compound annual growth rate of 5.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 15.71B | 38.61% |
| Dec 31, 2024 | 11.33B | -9.30% |
| Dec 29, 2023 | 12.50B | -28.31% |
| Dec 30, 2022 | 17.43B | 1.85% |
| Dec 31, 2021 | 17.12B | -11.89% |
| Dec 31, 2020 | 19.43B | 23.26% |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 614.44B |
| Johnson & Johnson | 420.78B |
| AbbVie | 361.58B |
| UnitedHealth Group | 245.88B |
| AstraZeneca | 243.29B |
| Novartis AG | 236.22B |
| Novo Nordisk | 225.09B |
| Abbott Laboratories | 225.01B |